Genovese Burford & Brothers Wealth & Retirement Plan Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-180	Closed	-$17K	–	381
2018 Q2	$17K	Hold	180	–	–	0.01%	270
2018 Q1	$16K	Hold	180	–	–	0.01%	281
2017 Q4	$17K	Buy	+180	New	+$15.1K	0.04%	156
2016 Q1	–	Sell	-162	Closed	-$11K	–	417
2015 Q4	$11K	Buy	+162	New	+$11K	0.01%	247

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's XBI Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2018, closing a stake of 180 shares — an estimated $17K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in XBI in Q4 2015 and held it in 4 quarters. The position peaked at $17K in Q2 2018. 432 funds tracked by Wall St. Rank hold XBI as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 180 State Street SPDR S&P Biotech ETF shares in Q3 2018, an estimated $17K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and held it in 4 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's State Street SPDR S&P Biotech ETF position peaked at $17K in Q2 2018.
432 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.